Literature DB >> 31058886

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method.

Thea Brennan-Krohn1, James E Kirby2.   

Abstract

As rates of multidrug-resistant (MDR) pathogens continue to rise, outpacing the development of new antimicrobials, novel approaches to treatment of MDR bacteria are increasingly becoming a necessity. One such approach is combination therapy, in which two or more antibiotics are used together to treat an infection against which one or both of the drugs may be ineffective alone. When two drugs, in combination, exert a greater than additive effect, they are considered synergistic. In vitro investigation of synergistic activity is an important first step in evaluating the possible efficacy of drug combinations. Two main in vitro synergy testing methods have been developed: the checkerboard array and the time-kill study. In this paper, we present an automated checkerboard array method that makes use of inkjet printing technology to increase the efficiency and accuracy of this technique, as well as a standard manual time-kill synergy method. The automated checkerboard array can serve as a high-throughput screening assay, while the manual time-kill study provides additional, complementary data on synergistic activity and killing. The checkerboard array is a modification of standard minimum inhibitory concentration (MIC) testing, in which bacteria are incubated with antibiotics at different concentration combinations and evaluated for growth inhibition after overnight incubation. Manual performance of the checkerboard array requires a laborious and error-prone series of calculations and dilutions. In the automated method presented here, the calculation and dispensing of required antibiotic stock solution volumes are automated through the use of inkjet printer technology. In the time-kill synergy assay, bacteria are incubated with the antibiotics of interest, both together and individually, and sampled at intervals over the course of 24 h for quantitative culture. The results can determine whether a combination is synergistic and whether it is bactericidal, and provide data on inhibition and killing of bacteria over time.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31058886      PMCID: PMC6698365          DOI: 10.3791/58636

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  33 in total

Review 1.  Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Clin Infect Dis       Date:  2005-03-22       Impact factor: 9.079

2.  The Poisoned Well: Enhancing the Predictive Value of Antimicrobial Susceptibility Testing in the Era of Multidrug Resistance.

Authors:  Thea Brennan-Krohn; Kenneth P Smith; James E Kirby
Journal:  J Clin Microbiol       Date:  2017-05-03       Impact factor: 5.948

3.  The Inoculum Effect in the Era of Multidrug Resistance: Minor Differences in Inoculum Have Dramatic Effect on MIC Determination.

Authors:  Kenneth P Smith; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

4.  Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Alejandro Pironti; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

5.  In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.

Authors:  Yiying Cai; Tze-Peng Lim; Jocelyn Teo; Suranthran Sasikala; Winnie Lee; Yanjun Hong; Eric Chun Yong Chan; Thean Yen Tan; Thuan-Tong Tan; Tse Hsien Koh; Li Yang Hsu; Andrea L Kwa
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

6.  In vitro evaluation of antibiotic synergy for polymyxin B-resistant carbapenemase-producing Klebsiella pneumoniae.

Authors:  Azza Elemam; Joseph Rahimian; Mehmet Doymaz
Journal:  J Clin Microbiol       Date:  2010-08-04       Impact factor: 5.948

7.  Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.

Authors:  T Tängdén; R A Hickman; P Forsberg; P Lagerbäck; C G Giske; O Cars
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

8.  Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents.

Authors:  Simona Bratu; Pooja Tolaney; Usha Karumudi; John Quale; Mohamad Mooty; Satyen Nichani; David Landman
Journal:  J Antimicrob Chemother       Date:  2005-05-25       Impact factor: 5.790

Review 9.  Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems.

Authors:  Oren Zusman; Tomer Avni; Leonard Leibovici; Amos Adler; Lena Friberg; Theodouli Stergiopoulou; Yehuda Carmeli; Mical Paul
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

10.  Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and blaNDM-5: Preparation for a Postantibiotic Era.

Authors:  Zackery P Bulman; Liang Chen; Thomas J Walsh; Michael J Satlin; Yuli Qian; Jürgen B Bulitta; Charles A Peloquin; Patricia N Holden; Roger L Nation; Jian Li; Barry N Kreiswirth; Brian T Tsuji
Journal:  MBio       Date:  2017-07-25       Impact factor: 7.867

View more
  9 in total

1.  Synergistic Combinations and Repurposed Antibiotics Active against the Pandrug-Resistant Klebsiella pneumoniae Nevada Strain.

Authors:  Thea Brennan-Krohn; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2019-08-23       Impact factor: 5.191

2.  Discovery of small-molecule inhibitors of multidrug-resistance plasmid maintenance using a high-throughput screening approach.

Authors:  Katelyn E Zulauf; James E Kirby
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-09       Impact factor: 11.205

Review 3.  Leveraging laboratory and clinical studies to design effective antibiotic combination therapy.

Authors:  Kathleen Davis; Talia Greenstein; Roberto Viau Colindres; Bree B Aldridge
Journal:  Curr Opin Microbiol       Date:  2021-10-08       Impact factor: 7.934

4.  Transcriptomics Reveals How Minocycline-Colistin Synergy Overcomes Antibiotic Resistance in Multidrug-Resistant Klebsiella pneumoniae.

Authors:  Thea Brennan-Krohn; Alexandra Grote; James E Kirby; Ashlee M Earl; Shade Rodriguez
Journal:  Antimicrob Agents Chemother       Date:  2022-01-18       Impact factor: 5.938

5.  Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli.

Authors:  Luísa V Zacharias; Natália C Moreira; Nathália Abichabki; Fernando Bellissimo-Rodrigues; Fernanda L Moreira; Jhohann R L Benzi; Tânia M C Ogasawara; Joseane C Ferreira; Camila M Ribeiro; Fernando R Pavan; Leonardo R L Pereira; Guilherme T P Brancini; Gilberto Ú L Braga; Antonio W Zuardi; Jaime E C Hallak; José A S Crippa; Vera L Lanchote; Rafael Cantón; Ana Lúcia C Darini; Leonardo N Andrade
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

6.  Wound Healing Properties and Antimicrobial Effects of Parkia clappertoniana Keay Fruit Husk Extract in a Rat Excisional Wound Model.

Authors:  Dominic Nkwantabisa Kuma; Alex Boye; Godwin Kwakye-Nuako; Yaw Duah Boakye; Justice Kwaku Addo; Ernest Amponsah Asiamah; Eugene Agyei Aboagye; Orleans Martey; Mainprice Akuoko Essuman; Victor Yao Atsu Barku
Journal:  Biomed Res Int       Date:  2022-07-23       Impact factor: 3.246

7.  In Vitro Assessment of the Combination of Antibiotics against Some Integron-Harbouring Enterobacteriaceae from Environmental Sources.

Authors:  Folake Temitope Fadare; Elsiddig A E Elsheikh; Anthony Ifeanyin Okoh
Journal:  Antibiotics (Basel)       Date:  2022-08-11

Review 8.  We Cannot Do It Alone: The Intersection of Public Health, Public Policy, and Clinical Microbiology.

Authors:  Rose A Lee; James E Kirby
Journal:  Clin Lab Med       Date:  2019-07-06       Impact factor: 1.935

Review 9.  New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Roman Manetsch; George A O'Doherty; James E Kirby
Journal:  Transl Res       Date:  2020-03-02       Impact factor: 7.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.